Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/38629| Title: | SEOM clinical guidelines in gestational trophoblastic disease (2017). | |
| Authors: | ||
| Keywords: | ||
| Mesh: | ||
| Issue Date: | Jan-2018 | |
| Citation: | Clin Transl Oncol.2018 Jan;(20)1:38-46 | |
| Abstract: | Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD. | |
| PMID: | 29149431 | |
| URI: | https://hdl.handle.net/20.500.12530/38629 | |
| Rights: | openAccess | |
| Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PMC5785593.pdf | 408.93 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.